Browse > Home / Stock Buzz / MDRNA INC(MRNA) 09/27 UPDATED ANALYSIS (MRNA, rated SELL)

MDRNA INC(MRNA) 09/27 UPDATED ANALYSIS (MRNA, rated SELL)

September 28, 2008

This past week started with announcement of attending and speaking to security analyst&institutions conference on Oct.7th. Then the anticipated de-listing & compliance letter was released thereafter the previous release. The stock traded all day friday with over 120k volume and it was +1 (penny) after all that and closed at $.45 cents. What I’d like to know is what is the purpose of speaking, a week from Monday, in front of security analysts, fund managers and institutions? With a stock price that has declined from $18 dollars, a balance sheet that is poor, earnings loss qtly getting larger and larger, and now a compliance letter and de-listing notification, how can the Ceo Mr.French hold his audience spellbound that day. With this record he should be standing in the crowd blending in rather than embarrassing himself any further. I don’t see him attracting anyones interest and that goes for any partner either, that he is trying to attain. Not with these statistics, past record, and current stock price on top of all the bad news this company has received lately and the wall street crisis and credit crunch going on right now! All I see is New Lows ahead!

MDRNA INC(MRNA) 09/27 UPDATED ANALYSIS (MRNA, rated SELL)

Subscribe To Site:
Full Post Feed | Summary Feed | Comments Feed

Written by admin · Filed Under Stock Buzz 

Comments

RSS feed | Trackback URI

Comments »

No comments yet.

Name (required)
E-mail (required - never shown publicly)
URI
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> in your comment.